Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (27 quarters reported)
$442M in Q2 2013 → $13.9M now. Hover for any quarter.
As reported for the quarter ended December 31, 2019. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| AT Audentes Therapeutics Inc | 7.6% | Trimmed 30% | 17,795 | $1.07M |
| AP Alexion Pharmaceuticals Inc | 6.5% | Trimmed 62% | 8,421 | $911K |
| Allena Pharmaceuticals Inc | 5.6% | Unchanged | 284,285 | $776K |
| Gilead Sciences Inc | 5.1% | Trimmed 62% | 10,898 | $708K |
| Penumbra Inc | 4.4% | Trimmed 71% | 3,699 | $608K |
| ZB Zimmer Biomet Hldgs Inc | 4.0% | Trimmed 79% | 3,689 | $552K |
| Biogen Inc | 3.9% | New | 1,839 | $546K |
| Nevro Corp | 3.8% | Trimmed 22% | 4,515 | $531K |
| A Anthem Inc | 3.6% | New | 1,669 | $504K |
| Humana Inc | 3.5% | New | 1,347 | $494K |
| CN Cigna Corp New | 3.3% | Trimmed 69% | 2,216 | $453K |
| IH Iqvia Hldgs Inc | 3.2% | Trimmed 66% | 2,926 | $452K |
| Biomarin Pharmaceutical Inc | 3.2% | Trimmed 82% | 5,329 | $451K |
| AP Aerie Pharmaceuticals Inc | 3.1% | Added 7.8% | 18,035 | $436K |
| AP Allergan PLC | 3.1% | Trimmed 69% | 2,282 | $436K |
| AP Arena Pharmaceuticals Inc | 3.1% | Trimmed 67% | 9,484 | $431K |
| CD Centene Corp Del | 3.1% | New | 6,838 | $430K |
| NA Novartis A G | 2.8% | Trimmed 60% | 4,270 | $392K |
| Hca Healthcare Inc | 2.5% | Trimmed 69% | 2,335 | $345K |
| Pfizer Inc | 2.1% | New | 7,492 | $294K |
| IM Icu Med Inc | 1.9% | New | 1,381 | $258K |
| D Dermira Inc | 1.8% | Trimmed 44% | 16,892 | $256K |
| Icon PLC | 1.7% | Trimmed 56% | 1,402 | $241K |
| Unitedhealth Group Inc | 1.7% | New | 791 | $233K |
| IT Irhythm Technologies Inc | 1.7% | Trimmed 73% | 3,389 | $231K |
| I Immunomedics Inc | 1.7% | New | 10,880 | $230K |
| AL Abbott Labs | 1.6% | New | 2,565 | $223K |
| Molina Healthcare Inc | 1.3% | Trimmed 81% | 1,387 | $188K |
| Edwards Lifesciences Corp | 1.3% | Trimmed 79% | 788 | $184K |
| FD Fluidigm Corp Del | 0.9% | Added 7.1% | 37,856 | $132K |
| Catalent Inc | 0.9% | Trimmed 84% | 2,231 | $126K |
| Morphosys Ag | 0.9% | New | 994 | $126K |
| Abbvie Inc | 0.8% | New | 1,269 | $112K |
| AM Axonics Modulation Tech Inc | 0.8% | Added 105% | 3,978 | $110K |
| CS Cardiovascular Sys Inc Del | 0.7% | Trimmed 66% | 1,985 | $96K |
| Vertex Pharmaceuticals Inc | 0.7% | New | 434 | $95K |
| Halozyme Therapeutics Inc | 0.6% | New | 4,650 | $82K |
| Amarin Corp PLC | 0.6% | New | 3,757 | $81K |
| CB Coherus Biosciences Inc | 0.5% | Trimmed 52% | 3,771 | $68K |
| Acorda Therapeutics Inc | 0.3% | Trimmed 7.7% | 18,342 | $37K |
| E Endologix Inc | 0.0% | Trimmed 15% | 2,440 | $4K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2019 · filed February 14, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| NA Novo-nordisk A S | Exited | −17,526 | −$6.17M | — |
| NS Nxp Semiconductors N V | Exited | −20,473 | −$2.23M | — |
| Microchip Technology Inc | Exited | −23,996 | −$2.23M | — |
| ZB Zimmer Biomet Hldgs Inc | Trimmed | −13,999 | −$2.09M | 4.0% |
| Biomarin Pharmaceutical Inc | Trimmed | −24,012 | −$2.03M | 3.2% |
| Twilio Inc | Exited | −15,783 | −$1.74M | — |
| Western Digital Corp | Exited | −26,326 | −$1.57M | — |
| Intuit | Exited | −5,722 | −$1.52M | — |
| SC Salesforce Com Inc | Exited | −10,032 | −$1.49M | — |
| AP Alexion Pharmaceuticals Inc | Trimmed | −13,715 | −$1.48M | 6.5% |
Showing the 10 largest of 82 changes.
quarter ended September 30, 2019 · filed November 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Exited | −73,100 | −$13.7M | — |
| NA Novo-nordisk A S | New | +17,526 | +$6.17M | 10.6% |
| AP Allergan PLC | Trimmed | −21,143 | −$3.56M | 2.1% |
| Qualcomm Inc | Exited | −46,200 | −$3.51M | — |
| Humana Inc | Exited | −10,284 | −$2.73M | — |
| Amgen Inc | Exited | −13,600 | −$2.51M | — |
| AG Alibaba Group Hldg Ltd | Trimmed | −13,639 | −$2.28M | 0.7% |
| NS Nxp Semiconductors N V | New | +20,473 | +$2.23M | 3.8% |
| AP Alexion Pharmaceuticals Inc | New | +22,136 | +$2.17M | 3.7% |
| DW Disney Walt Co | Exited | −12,429 | −$1.74M | — |
Showing the 10 largest of 107 changes.
quarter ended June 30, 2019 · filed August 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Added | +48,800 | +$9.11M | 14.5% |
| Qualcomm Inc | Trimmed | −54,100 | −$4.11M | 3.7% |
| AP Allergan PLC | Added | +17,012 | +$2.85M | 5.1% |
| Amgen Inc | New | +13,600 | +$2.51M | 2.7% |
| Biomarin Pharmaceutical Inc | New | +25,610 | +$2.19M | 2.3% |
| Humana Inc | Exited | −8,200 | −$2.18M | — |
| Unitedhealth Group Inc | Trimmed | −7,910 | −$1.93M | 0.3% |
| AG Alibaba Group Hldg Ltd | Added | +10,651 | +$1.8M | 2.9% |
| DW Disney Walt Co | New | +12,429 | +$1.74M | 1.8% |
| PO Progressive Corp Ohio | New | +20,617 | +$1.65M | 1.7% |
Showing the 10 largest of 110 changes.
quarter ended March 31, 2019 · filed May 15, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Qualcomm Inc | New | +100,300 | +$5.72M | 6.6% |
| IQ Invesco Qqq Tr | New | +24,300 | +$4.37M | 5.0% |
| Allakos Inc | Exited | −88,079 | −$4.3M | — |
| NT Neon Therapeutics Inc | Trimmed | −473,233 | −$3.06M | 2.7% |
| IT Ishares Tr | Exited | −68,100 | −$2.66M | — |
| ST Spark Therapeutics Inc | Trimmed | −22,603 | −$2.57M | 0.5% |
| Unity Biotechnology Inc | Trimmed | −302,768 | −$2.44M | 0.1% |
| Stryker Corp | New | +11,607 | +$2.29M | 2.6% |
| Humana Inc | New | +8,200 | +$2.18M | 2.5% |
| CN Cigna Corp New | Exited | −10,700 | −$2.03M | — |
Showing the 10 largest of 123 changes.
quarter ended December 31, 2018 · filed February 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CC Cigna Corporation | Exited | −27,700 | −$5.77M | — |
| IT Ishares Tr | Exited | −15,000 | −$3.41M | — |
| IT Ishares Tr | New | +68,100 | +$2.66M | 3.3% |
| IT Ishares Tr | Exited | −15,200 | −$2.56M | — |
| MN Mylan N V | Exited | −69,449 | −$2.54M | — |
| Jazz Pharmaceuticals PLC | Exited | −14,027 | −$2.36M | — |
| CN Cigna Corp New | New | +10,700 | +$2.03M | 2.5% |
| S Square Inc | Exited | −453,000 | −$1.96M | — |
| Microchip Technology Inc | New | +26,975 | +$1.94M | 2.4% |
| Spotify Technology S A | Exited | −10,542 | −$1.91M | — |
Showing the 10 largest of 128 changes.
quarter ended September 30, 2018 · filed November 13, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Exited | −52,700 | −$9.05M | — |
| NT Neon Therapeutics Inc | Added | +829,833 | +$5.82M | 4.5% |
| CC Cigna Corporation | New | +27,700 | +$5.77M | 4.4% |
| Allakos Inc | New | +88,125 | +$3.55M | 2.7% |
| IT Ishares Tr | New | +15,000 | +$3.41M | 2.6% |
| Baidu Inc | Exited | −9,738 | −$2.37M | — |
| IT Ishares Tr | Exited | −50,500 | −$2.19M | — |
| IT Ishares Tr | Trimmed | −12,600 | −$2.12M | 2.0% |
| TS Taiwan Semiconductor Mfg Ltd | New | +37,749 | +$1.67M | 1.3% |
| Hologic Inc | Exited | −33,991 | −$1.35M | — |
Showing the 10 largest of 124 changes.
quarter ended June 30, 2018 · filed August 14, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | New | +52,700 | +$9.05M | 7.3% |
| IT Ishares Tr | New | +27,800 | +$4.55M | 3.7% |
| Unity Biotechnology Inc | New | +308,764 | +$4.08M | 3.3% |
| Allena Pharmaceuticals Inc | Trimmed | −277,402 | −$3.61M | 3.1% |
| Bristol Myers Squibb Co | Exited | −55,719 | −$3.52M | — |
| Microsoft Corp | Exited | −27,467 | −$2.51M | — |
| IT Ishares Tr | New | +50,500 | +$2.19M | 1.8% |
| BI Baxter Intl Inc | Trimmed | −25,619 | −$1.89M | 1.0% |
| Bristol Myers Squibb Co | Exited | −26,000 | −$1.65M | — |
| Spotify Technology S A | New | +9,164 | +$1.54M | 1.2% |
Showing the 10 largest of 123 changes.
quarter ended March 31, 2018 · filed May 15, 2018
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SB Sienna Biopharmaceuticals In | Trimmed | −283,568 | −$5.33M | 0.4% |
| Bristol Myers Squibb Co | New | +55,719 | +$3.52M | 3.8% |
| MN Mylan N V | New | +74,850 | +$3.08M | 3.3% |
| Dish Network Corp | Exited | −2,192,000 | −$2.39M | — |
| Jazz Pharmaceuticals PLC | New | +15,538 | +$2.35M | 2.5% |
| Servicenow Inc | Exited | −13,664 | −$1.78M | — |
| A Anthem Inc | Added | +8,064 | +$1.77M | 3.3% |
| Microsoft Corp | Added | +19,198 | +$1.75M | 2.7% |
| TS Tableau Software Inc | New | +20,886 | +$1.69M | 1.8% |
| Bristol Myers Squibb Co | New | +26,000 | +$1.65M | 1.8% |
Showing the 10 largest of 103 changes.
Loading...
